Experience
(Northern District of California, Delaware) Represented a SaaS company in trade secret, breach of contract, patent infringement, and false advertising litigation brought by a competitor. Successfully defeated a motion for preliminary injunction. The litigation ultimately resulted in a stipulated dismissal with prejudice.
(Southern District of California) Represented Snap-on and Mitchell Repair Information Company in connection with trade secret and data theft claims against a foreign competitor. Secured preliminary and permanent injunctive relief.
(Southern District of California) Represented the National Institute of Aviation Research at Wichita State University (NIAR) in a trade secret case related to programs for converting passenger jets from passenger use to cargo use. After a year of litigation, the plaintiffs dismissed the case, with prejudice, without any concessions or payment by NIAR.
(District of Delaware) Represented Nevro Corp., a public global medical device company, in its patent battle against competitor Stimwave Technologies, Inc. Secured a preliminary injunction for Nevro, after an all-day evidentiary hearing. The case subsequently settled after Stimwave stipulated to a permanent injunction agreeing not to infringe the patents.
(District of Delaware) Represented Xilinx in a 16-patent case, including a counterclaim by Xilinx against ADI.
(District of Delaware). Represented DNA Genotek in litigation asserting patent involving DNA sample collection devices. Obtained eight-figure settlement and ongoing royalty following favorable IPR and claim construction proceedings.
(Central District of California). Represented several Alcon entities in patent litigation regarding femtosecond lasers for eye surgery. Prevailed on summary judgment that the three asserted patents were not infringed by the accused devices.
(District of Nevada). Represented Sandoz in Hatch-Waxman litigation regarding the company’s application to sell an injectable oncology drug. Of the 14 claims originally asserted by Spectrum against Sandoz’s proposed generic version of levoleucovorin, successfully eliminated all but two claims before trial. After a five-day bench trial, the court found clear and convincing evidence of obviousness and invalidated the remaining two claims.
Represented international corporations in a multi-year arbitration in connection with the operation of an open-pit mine. Obtained a favorable award for the clients, along with the rejection of the respondent’s counterclaims, and subsequently obtained confirmation and judgment on the entire award.
Represented communications companies in connection with patent litigation regarding television distribution and video services technology.